首页> 外文期刊>Breast care >13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus – Opinion of a German Team of Experts (Zurich 2013)
【24h】

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus – Opinion of a German Team of Experts (Zurich 2013)

机译:2013年第13届圣加仑国际乳腺癌大会:早期乳腺癌的主要疗法证据,争议,共识–德国专家小组的意见(Zurich 2013)

获取原文
           

摘要

The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.
机译:关于原发性乳腺癌治疗的国际共识会议每两年在瑞士圣加仑举行一次。圣加仑的小组由来自不同国家的国际专家组成。从德国的角度来看,根据AGO的建议和德国日常实践的S3准则来解释投票结果似乎是合理的。因此,由八名乳腺癌专家组成的团队(其中两名是国际圣加仑小组成员)对圣加仑共识会议(2013年)的投票结果发表了评论。在今年的圣加仑会议上,主要议题是乳房和腋窝的外科手术问题,放射治疗和全身治疗选择以及肿瘤生物学的临床意义。还广泛讨论了支持个体治疗决策的多基因测定的临床实用性。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号